Generic Drug Analysis & Statistics in Europe Countries, August 2014 (p2)

31-80 of 77 reports

Purchase Reports From Reputable Market Research Publishers

Biofarm SA (Romania) - Company Profile

Biofarm SA (Romania) - Company Profile

  • $ 64
  • Company report
  • August 2014
  • by SeeNews - Research & Profiles

Biofarm SA is the leading Romanian generic pharmaceuticals producer. The company meets Good Manufacturing Practice (GMP) requirements. Biofarm SA is listed on the first tier on the Bucharest stock exchange. ...

  • Industries : Generic Drug
  • Countries : Romania
Profarma Sh.a. (formerly known as Prodhime Farmaceutike Sh.a.) (Albania) - Company Profile

Profarma Sh.a. (formerly known as Prodhime Farmaceutike Sh.a.) (Albania) - Company Profile

  • $ 64
  • Company report
  • July 2014
  • by SeeNews - Research & Profiles

Profarma Sh.a. is one of the leading pharmaceutical companies in Albania. It produces a number of essential generic pharmaceutical products, including perfusions, solutions for injections in small volumes, ...

  • Industries : Generic Drug
  • Countries : Albania
Belgium Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Belgium Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Belgium’s rapidly ageing population, traditionally high per capita consumption of medicines and a well-developed healthcare system will combine to continue ...

  • Industries : Generic Drug
  • Countries : Belgium
France Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

France Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: With the aim of improving patient safety and restoring confidence in the country’s drug regulatory process, in December 2011 the French parliament approved ...

  • Industries : Generic Drug
  • Countries : France
Portugal Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Since the approval of an EU/ECB/IMF economic rescue package in May 2011, cost cutting measures have taken their toll on all segments – including the pharmaceutical and healthcare market . ...

  • Industries : Generic Drug
  • Countries : Portugal
Belgium Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Belgium Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Belgium, much like most of the other regional industries, is expected to post negative year-onyear (y-o-y) value growth in its 2012 pharmaceutical revenues because ...

  • Industries : Generic Drug
  • Countries : Belgium
Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Bulgaria’s pharmaceutical industry will be under some pressure in 2012 due to a weakening economic outlook and the tightening of publicly funded healthcare services. However, we have broadly ...

  • Industries : Generic Drug
  • Countries : Bulgaria
Sweden Business Projection Industry Update Quarter 1 2012

Sweden Business Projection Industry Update Quarter 1 2012

  • $ 1 208
  • Industry report
  • December 2013
  • by Business Monitor International

Core Views S weden’s status as an open-trade-oriented economy means that the ongoing European debt and economic crisis poses significant downside risks to Swedish growth in 2012. S weden is among the ...

  • Industries : Generic Drug
  • Countries : Sweden
Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2013
  • by Business Monitor International

BMI View: Out-of-pocket spending will continue to be the main driver behind the growth of Bulgaria’s pharmaceutical industry, though this feature also makes the industry highly vulnerable to the wide ...

  • Industries : Generic Drug
  • Countries : Bulgaria
Portugal Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2013
  • by Business Monitor International

BMI View: The EU/IMF economic rescue package, approved in May 2011, has widespread implications for the pharmaceutical segment, including changes to reimbursement, the obligation to prescribe by active ...

  • Industries : Generic Drug
  • Countries : Portugal
Belgium Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Belgium Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2013
  • by Business Monitor International

BMI View: The expected growth of Belgium’s ageing population will have an unprecedented effect on the provision of healthcare. The elderly require more medical check-ups and care than young people due ...

  • Industries : Generic Drug
  • Countries : Belgium
Sintofarm SA (Romania) - Company Profile

Sintofarm SA (Romania) - Company Profile

  • $ 64
  • Company report
  • November 2013
  • by SeeNews - Research & Profiles

Sintofarm SA is a Romanian generic drugs producer. The company is in compliance with the Good Manufacturing Practice (GMP) standard since 2004. Last updated on Sept 10, 2013.

  • Industries : Generic Drug
  • Countries : Romania
Terapia SA (Romania) - Company Profile

Terapia SA (Romania) - Company Profile

  • $ 64
  • Company report
  • November 2013
  • by SeeNews - Research & Profiles

Terapia SA is the biggest generics drugs producer in Romania.

  • Industries : Generic Drug
  • Countries : Romania
Europharm SA (Romania) - Company Profile

Europharm SA (Romania) - Company Profile

  • $ 64
  • Company report
  • November 2013
  • by SeeNews - Research & Profiles

Europharm SA is a leading Romanian generic drugs producer. Its productions facilites are based in Brasov, central Romania. Last updated on Aug 2, 2013

  • Industries : Generic Drug
  • Countries : Romania
Balkanpharma - Razgrad AD (Bulgaria) - Company Profile

Balkanpharma - Razgrad AD (Bulgaria) - Company Profile

  • $ 64
  • Company report
  • November 2013
  • by SeeNews - Research & Profiles

Balkanpharma-Razgra dAD is the leading antibiotics producer in Bulgaria and one of the leaders on the Balkan Peninsula. The company exports its products to Australia, Europe, North America and Asia. Balkanpharma ...

  • Industries : Generic Drug
  • Countries : Bulgaria
Grupo Ferrer Internacional, S.A.: Ingredients - Company Profile and SWOT Report

Grupo Ferrer Internacional, S.A.: Ingredients - Company Profile and SWOT Report

  • $ 125
  • Company report
  • September 2013
  • by Canadean Ltd

Synopsis Canadean's "Grupo Ferrer Internacional, S.A.: Ingredients - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company ...

  • Industries : Generic Drug
  • Countries : France, Spain, Europe
Russia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Russia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2013
  • by Business Monitor International

BMI View: Russia continues to offer both outsized risks and outsized opportunities for foreign drugmakers, according to BMI. Positive trends in recent years include increasing state coverage of medicines ...

  • Industries : Generic Drug
  • Countries : Russian Federation
Portugal Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2013
  • by Business Monitor International

BMI View: Portugal is typical of many Western European industries. It is mature, with little scope for growth and is subject to downward pressures on pricing and the demands of an aging population. Following ...

  • Industries : Generic Drug
  • Countries : Portugal
Generics Market Overview in the Netherlands

Generics Market Overview in the Netherlands

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Generic Drug
  • Countries : Netherlands
Generics Market Overview in Spain

Generics Market Overview in Spain

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Generic Drug
  • Countries : Spain
Generics Market Overview in Italy

Generics Market Overview in Italy

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Generic Drug
  • Countries : Italy
Generics Market Overview in Germany

Generics Market Overview in Germany

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Generic Drug
  • Countries : Germany
Generics Market Overview in Belgium

Generics Market Overview in Belgium

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Generic Drug
  • Countries : Belgium
Generics Market Overview in the United Kingdom

Generics Market Overview in the United Kingdom

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Generic Drug
  • Countries : United Kingdom
Generics Market Overview in France

Generics Market Overview in France

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Generic Drug
  • Countries : France
Pharma Wholesale and Distribution Market: World Outlook 2013-2023

Pharma Wholesale and Distribution Market: World Outlook 2013-2023

  • $ 2 846
  • Industry report
  • June 2013
  • by Visiongain

Report Details Discover trends and revenue potential in distributing and wholesaling of medicines Where's the drug wholesaling and distribution market heading? Visiongain's updated report predicts revenues ...

  • Industries : Generic Drug
  • Countries : World, China, Europe, United States, Japan, India, Brazil, Russian Federation, France, United Kingdom, Spain, Italy, Germany, Asia
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

  • $ 3 500
  • Industry report
  • December 2012
  • by GBI Research

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence ...

  • Industries : Generic Drug
  • Countries : Europe, United States, World, Japan, Spain, Italy, France, Germany
Apotex, Inc.: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Apotex, Inc.: Pharmaceuticals and Healthcare Company Profile & SWOT Report

  • $ 125
  • Company report
  • November 2012
  • by ICD Research

Synopsis ICD Research's "Apotex, Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Generic Drug
  • Countries : Canada, Czech Republic, New Zealand, Australia, Netherlands, Mexico, Poland, Belgium, World, Europe, Oceania, North America, United Kingdom
Global Biosimilars Market - Products, Applications and Regulations

Global Biosimilars Market - Products, Applications and Regulations

  • $ 4 320
  • Industry report
  • November 2012
  • by Industry Experts

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies' position ...

  • Industries : Generic Drug
  • Countries : World, Europe, United States, United Kingdom, Germany, France, Spain, Italy, India, South Korea
Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 1 495
  • Industry report
  • August 2012
  • by MarketLine

It includes detailed data on industry size and sector ation, textual analysis of the key trends and competitive landscape, and profiles of the leading firms . This incisive report provides expert analysis ...

  • Industries : Generic Drug
  • Countries : World, Europe, United States, United Kingdom, Netherlands, France, Germany, Japan, Canada, Spain, Italy, Belgium, China
49 reports

Download Unlimited Documents from Trusted Public Sources

Biosimilars Market Forecast in Europe

  • After Generics It's the Turn of Biosimilars, a Budding Market
  • September 2014
    2 pages
  • Biosimilars  

    Drug  

  • Europe  

    Spain  

    World  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.